Xeris Biopharma Holdings, Inc. SEC filings XERS
Xeris Biopharma Holdings, Inc. has 345 filings in SEC EDGAR's recent list, going back to Jul 2, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Nov 5, 2026 | — |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 3 | Initial insider ownership | Nov 4, 2026 | Nov 2, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 13, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 29, 2026 | Sep 28, 2026 |
| 144 | Notice of proposed sale | Sep 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 1, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 1, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 12, 2026 |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 17, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 6, 2026 |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 144 | Notice of proposed sale | Jul 6, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 3 | Initial insider ownership | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jun 11, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 144 | Notice of proposed sale | Jun 3, 2026 | — |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 1, 2026 | May 1, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 144 | Notice of proposed sale | Mar 30, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| S-8 | Employee stock plan registration | Mar 2, 2026 | — |
| 10-K | Annual report | Mar 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 8, 2026 |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 144 | Notice of proposed sale | Dec 12, 2025 | — |
| 4 | Insider transaction | Dec 2, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 144 | Notice of proposed sale | Nov 13, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Sep 15, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Sep 11, 2025 |
| 144 | Notice of proposed sale | Sep 11, 2025 | — |
| 4 | Insider transaction | Aug 29, 2025 | Aug 28, 2025 |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2025 | Jun 3, 2025 |
| EFFECT | Filing | May 13, 2025 | — |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 9, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 2, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 28, 2025 |
| 3 | Initial insider ownership | Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 28, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 20, 2025 |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| 3 | Initial insider ownership | Mar 7, 2025 | Feb 25, 2025 |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| UPLOAD | Letter from the SEC | Aug 13, 2024 | — |
| 4 | Insider transaction | Aug 12, 2024 | Aug 9, 2024 |
| 4 | Insider transaction | Aug 9, 2024 | Jan 29, 2022 |
| 4 | Insider transaction | Aug 9, 2024 | Jan 29, 2022 |
| 4 | Insider transaction | Aug 9, 2024 | Jan 29, 2022 |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| CORRESP | Letter to the SEC | Aug 6, 2024 | — |
| 4 | Insider transaction | Aug 2, 2024 | Jan 29, 2022 |
| 4 | Insider transaction | Aug 2, 2024 | Aug 1, 2024 |
| 3 | Initial insider ownership | Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2024 | Aug 1, 2024 |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jul 8, 2024 | Jul 7, 2024 |
| CORRESP | Letter to the SEC | Jun 21, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2024 | — |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Apr 11, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 14, 2024 |
| S-8 | Employee stock plan registration | Mar 6, 2024 | — |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Other events
|
Mar 6, 2024 | Mar 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Jan 31, 2024 | Jan 31, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XERS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1867096
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.